WO2007133820A3 - Diaryl triazolones as cb1 antagonists - Google Patents

Diaryl triazolones as cb1 antagonists Download PDF

Info

Publication number
WO2007133820A3
WO2007133820A3 PCT/US2007/060599 US2007060599W WO2007133820A3 WO 2007133820 A3 WO2007133820 A3 WO 2007133820A3 US 2007060599 W US2007060599 W US 2007060599W WO 2007133820 A3 WO2007133820 A3 WO 2007133820A3
Authority
WO
WIPO (PCT)
Prior art keywords
diaryl
triazolones
disorders
compounds
formula
Prior art date
Application number
PCT/US2007/060599
Other languages
French (fr)
Other versions
WO2007133820A2 (en
Inventor
Alan J Hutchison
Jianmin Mao
George D Maynard
Wallace C Pringle
He Zhao
David J Wustrow
Original Assignee
Neurogen Corp
Alan J Hutchison
Jianmin Mao
George D Maynard
Wallace C Pringle
He Zhao
David J Wustrow
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp, Alan J Hutchison, Jianmin Mao, George D Maynard, Wallace C Pringle, He Zhao, David J Wustrow filed Critical Neurogen Corp
Publication of WO2007133820A2 publication Critical patent/WO2007133820A2/en
Publication of WO2007133820A3 publication Critical patent/WO2007133820A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Diaryl triazolones of Formula I are provided, in which the variables are as described herein. Such compounds may be used to modulate CB1 activity in vivo or in vitro, and are particularly useful in the treatment of conditions responsive to CB1 modulation in humans, domesticated companion animals and livestock animals, including appetite disorders, obesity and addictive disorders. Pharmaceutical compositions and methods for using diaryl traizolones of Formula I to treat such disorders are provided, as are methods for using such compounds as ligands for receptor localization studies and various in vitro assays.
PCT/US2007/060599 2006-01-19 2007-01-17 Diaryl triazolones as cb1 antagonists WO2007133820A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76012306P 2006-01-19 2006-01-19
US60/760,123 2006-01-19

Publications (2)

Publication Number Publication Date
WO2007133820A2 WO2007133820A2 (en) 2007-11-22
WO2007133820A3 true WO2007133820A3 (en) 2008-08-28

Family

ID=38694569

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/060599 WO2007133820A2 (en) 2006-01-19 2007-01-17 Diaryl triazolones as cb1 antagonists

Country Status (1)

Country Link
WO (1) WO2007133820A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120052A1 (en) 2011-03-08 2012-09-13 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
WO2012120054A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258957B1 (en) * 1995-06-09 2001-07-10 Bayer Aktiengesellschaft N-aryl-1,2,4-triazolin-5-ones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258957B1 (en) * 1995-06-09 2001-07-10 Bayer Aktiengesellschaft N-aryl-1,2,4-triazolin-5-ones

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ENDERS ET AL.: "Preparation and Application of 1,3,4-Triphenyl-4,5-dihydro-1H-1,2,4-triazol-5-ylidene, A Stable Carbene", vol. 8, February 2003 (2003-02-01), pages 1292 - 1295 *

Also Published As

Publication number Publication date
WO2007133820A2 (en) 2007-11-22

Similar Documents

Publication Publication Date Title
WO2006049941A3 (en) Diaryl ureas as cb1 antagonists
TW200716594A (en) Substituted heteroaryl CB1 antagonists
WO2006052542A3 (en) Arylalkyl ureas as cb1 antagonists
WO2007146761A3 (en) Diaryl pyrimidinones and related compounds
WO2009012482A3 (en) 5-membered heterocyclic amides and related compounds
WO2008016811A3 (en) Aminopiperidines and realted compounds
WO2007133561A3 (en) Substituted azaspiro derivatives
WO2008066789A3 (en) Heteroaryl amide derivatives
WO2006078992A3 (en) Heteroaryl substituted piperazinyl-pyridine analogues
WO2005110982A3 (en) Substituted 1-benzyl-4-substituted piperazine analogues
MY148461A (en) Heteroaryl amide analogues as p2x7 antagonists
WO2006026135A3 (en) Substituted biaryl piperazinyl-pyridine analogues
WO2007101007A3 (en) Aryl sulfonyl heterocycles
WO2007140383A3 (en) Spirocyclic sulfonamides and related compounds
WO2006076646A3 (en) Heteroaryl substituted quinolin-4-ylamine analogues
WO2006081388A3 (en) Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
WO2007106349A3 (en) Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
WO2005042498A3 (en) 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
WO2006042289A3 (en) Substituted biaryl quinolin-4-ylamine analogues
WO2006089076A3 (en) Thiazole amides, imidazole amides and related analogues
WO2005007648A3 (en) Biaryl piperazinyl-pyridine analogues
WO2008024433A3 (en) Haloalkyl-substituted pyrimidinone derivatives
WO2005007652A3 (en) Substituted quinolin-4-ylamine analogues
WO2008024438A3 (en) 2-phenoxy pyrimidinone analogues
WO2008033739A3 (en) Benzimidazole carboxamide derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07811784

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07811784

Country of ref document: EP

Kind code of ref document: A2